The Serum Institute of India (SII) has increased its capacity to produce 240 million AstraZeneca Covid-19 doses making it capable to export large volumes of the vaccine.
The company’s CEO Adar Poonawalla said the company would be able to export 20 to 30 million Covid-19 vaccine doses in November this year.
The Serum Institute of India (SII) has increased its capacity to produce 240 million AstraZeneca Covid-19 doses making it capable to export large volumes of the vaccine.
According to Reuters, the company’s CEO Adar Poonawalla said it will produce 220-240 million AstraZeneca vaccine doses.
He added the company may be able to export up to 30 million doses a month in November and December.
He said the company has revamped its infrastructure to produce the required Covid-19 doses.
Poonaawalla said SII would also make the single-dose Sputnik Light vaccine.
He also said the company would also produce 50 million to 100 million doses of the Novavax vaccine by the end of this year.